Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA3KV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,766
Award facts
- Contract value 100% obligated
- $51,766.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $51,766.26 delivery order to Amerisourcebergen Drug Corp on May 1, 2026, for XELJANZ XR 11 MG tablets (30-count units), with an ultimate completion date of May 4, 2026.
This is a firm fixed-price delivery order under a DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the pharmaceutical distributor and medical supplier for Defense Health Agency and military healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FA3KV?
SPE2DR26FA3KV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 1, 2026.
How much is contract SPE2DR26FA3KV worth?
The government has obligated $51,766 on SPE2DR26FA3KV.
Is contract SPE2DR26FA3KV an order under another contract?
Yes. SPE2DR26FA3KV is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA3KV competed?
The extent of competition for SPE2DR26FA3KV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award